NRAS Mutations with Low Allele Burden have Independent Prognostic Significance for Patients with Lower Risk Myelodysplastic Syndromes

Documenti analoghi

• Clinical Effect of Point Mutations in Myelodysplastic Syndromes
  di: Bejar, Rafael, et al.
  Pubblicazione: (2011)
• Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
  di: Bejar, Rafael, et al.
  Pubblicazione: (2012)
• TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
  di: Bejar, Rafael, et al.
  Pubblicazione: (2014)
• The Search for Better Prognostic Models in Myelodysplastic Syndromes
  di: Santos, Fabio P. S., et al.
  Pubblicazione: (2011)
• Toll-like receptor alterations in myelodysplastic syndrome
  di: Wei, Yue, et al.
  Pubblicazione: (2013)